ALLEVYN◊ GENTLE BORDER
Foam Dressing
More information coming soon.
Other Wound Care Solutions
References
1. Smith & Nephew 2016. ALLEVYN Gentle Border Heel Gen 2 - physical evaluation. Internal Report. DS/16/465/R.
2. Smith & Nephew 2017. ALLEVYN Gentle Border Gen 2 - Physical Evaluation. Internal Report. DS/16/424/R V3.
3. Rafter L, Reynolds T, Rafter M.An audit of patient outcomes in the management of skin tears using silicone dressings. Wounds UK. 2016;12(2):70-78
4. Hurd T, Gregory L, Jones A, Brown S.A multi-centre in-market evaluation of ALLEVYN Gentle Border. Wounds UK. 2009;5(3):32-44.
5. Vowden K, Harding K, Moiemen N, Drysdale K, Mistry C. An open, prospective randomised, multi-centre clinical evaluation of a hydrocellular silicone foam dressing* in the management of exuding chronic and acute wounds. Paper presented at: EWMA; 2011; Brussels.
6. Smith & Nephew 2008. ALLEVYN Gentle Border dressings assessment in terms of retention on thighs - HVT046. Internal Report. GMCA-DOF/04.
7. Smith & Nephew 2017. An open, prospective, randomised, comparative volunteer trial to compare the performance of silicone adhesive dressings. Internal Report. GMCA-DOF-10.
8. Smith & Nephew 2017. An open, prospective, randomised, comparative study to compare the performance of ALLEVYN Gentle Border Multisite with an alternative silicone adhesive dressing. Internal Report. GMCA-DOF-09.
9. Smith & Nephew 2017. ALLEVYN Gentle Border wound model - 10 x 10. Internal Report. DS/17/491/R.
10. Smith & Nephew 2016. ALLEVYN Gentle Border Heel Gen 2 - physical evaluation. Internal Report. DS/16/465/R.
11. Smith & Nephew 2017. ALLEVYN Gentle Border Gen 2 - Physical Evaluation. Internal Report. DS/16/424/R V3.
12. Smith & Nephew 2019. Use of Moisture Vapour Permeability (MVP) and Moisture Vapour Transmission Rate (MVTR) data to support product claims referring to moist wound healing. Internal report. EO.AWM.PCSgen.001.v2
13. Smith & Nephew 2007. Bacterial Barrier Testing (wet-wet) on samples of ALLEVYN Gentle, ALLEVYN Gentle Border and competitor dressings with a 7 day test duration against S. marcescens. Internal Report. 0712089.